Related Experiment Video

Updated: Aug 18, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Late outcomes in patients with surgically treated congenital heart disease

Amy H Schultz1, Gil Wernovsky

  • 1The Cardiac Center, The Children's Hospital of Philadelphia, PA 19104, USA.

Seminars in Thoracic and Cardiovascular Surgery. Pediatric Cardiac Surgery Annual
|April 9, 2005
PubMed

Insights

Improving long-term outcomes for congenital heart disease (CHD) requires addressing significant morbidities beyond mortality. Ongoing studies are crucial to understand and manage these complex late effects in CHD patients.

Area of Science:

  • Pediatric Cardiology
  • Adult Congenital Heart Disease
  • Cardiovascular Surgery

Background:

  • Optimizing late outcomes is a key goal for congenital heart disease (CHD) care.
  • Beyond mortality, significant morbidities impact patients post-surgery.
  • These include reintervention, cardiovascular issues, exercise intolerance, neurocognitive deficits, pregnancy complications, insurance challenges, chronic medications, and reduced quality of life.

Purpose of the Study:

  • To highlight the importance of optimizing late outcomes in congenital heart disease (CHD).
  • To emphasize the range of morbidities that require consideration in long-term CHD management.
  • To underscore the challenges and necessity of long-term follow-up studies in CHD.

Main Methods:

  • Review of long-term outcomes in congenital heart disease (CHD).
  • Discussion of management changes over three decades for specific conditions: tetralogy of Fallot, D-transposition of the great arteries, and hypoplastic left heart syndrome.
  • Analysis of challenges in predicting outcomes and the need for continued follow-up studies.

Main Results:

  • Long-term outcome studies are challenging due to evolving management strategies.
  • Interpreting outcomes is complicated by changes in medical and surgical care over time.
  • Specific case examples illustrate the complexity of long-term CHD follow-up.

Conclusions:

  • Optimizing late outcomes and minimizing morbidities are essential in congenital heart disease (CHD) care.
  • The evolution of CHD management necessitates robust, ongoing long-term follow-up studies.
  • Predicting future outcomes requires a comprehensive understanding of historical and current treatment impacts.

More Related Videos

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...